CM
AXDX

Caption Management’s Accelerate Diagnostics AXDX Stock Holding History

Caption Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,880
Closed -$487K – 859
2019
Q4 		$487K Sell
2,880
-4,120
-59% -$680K 0.02% 631
2019
Q3 		$1.3M Buy
7,000
+3,150
+82% +$609K 0.07% 327
2019
Q2 		$881K Buy
+3,850
New +$753K 0.04% 394

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Caption Management's AXDX Position: Q1 2020 in Review

Caption Management sold out of Accelerate Diagnostics (AXDX) in Q1 2020, closing a stake of 2,880 shares — an estimated $487K sold.

Caption Management first reported a position in AXDX in Q2 2019 and held it in 3 quarters. The position peaked at $1.3M in Q3 2019. 110 funds tracked by Wall St. Rank hold AXDX as of Q1 2020.

  • Caption Management reported no remaining Accelerate Diagnostics position as of Q1 2020 after selling out during the quarter.
  • Caption Management sold 2,880 Accelerate Diagnostics shares in Q1 2020, an estimated $487K.
  • Caption Management first reported a position in Accelerate Diagnostics in Q2 2019 and held it in 3 quarters.
  • Caption Management's Accelerate Diagnostics position peaked at $1.3M in Q3 2019.
  • 110 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2020.

Based on Caption Management's 13F filing for Q1 2020, filed 15 May 2020.